Andrea M Thomas, DO
Family Practice · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Sutter Auburn Faith Hospital · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Thomas’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Auburn Faith HospitalAuburn, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Auburn Faith Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2.01) · 312 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.62 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 160.66 (100.73 to 220.58) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 241 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,272 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,484 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,442 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.11 (1.72 to 6.49) · 442 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.12 (0.47 to 3.78) · 417 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.72 (0.67 to 18.77) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.26 (4.11 to 12.4) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.18) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 1.3) · 1,845 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 34 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.9 · 178 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -30.1 · 250 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.5) · 58 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8 to 16.4) · 58 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 95 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (9 to 15.2) · 1,787 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 473 cases | No different | Jan 2024 – Dec 2024 |
What patients said (563 patients answered, 27% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$25,235
Medicare paid this office $25,235 for 252 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 130 | $10,067 | $74 |
| Short return visit (20+ min) | 97 | $5,573 | $54 |
| Long return visit (40+ min) | 17 | $2,245 | $132 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 13 | $1,957 | $140 |
| Automated urinalysis test | 19 | $44 | $2 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
252 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 11% · Women 57% · Also on Medicaid 17% · Health risk score 1.15. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 69% · Coronary heart disease 31% · Chronic kidney disease 23% · Depression 21% · Diabetes 20% · COPD 17% · Atrial fibrillation 17% · Heart failure 14% · Cancer 10% · Dementia 5% · Stroke 5%.
The office billed $122,437, Medicare allowed $40,115 and paid $25,235; for 377 services of 39 kinds; $1,675 of it was for drugs given in the office and $23,560 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 252 | 377 | 73 | 1.15 | $122,437 | $25,235 |
| 2023 | 409 | 1,064 | 73 | 1.05 | $406,528 | $67,467 |
| 2022 | 177 | 404 | 72 | 1.08 | $166,116 | $30,444 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 211 | $24,922 | $72 |
| Short return visit (20+ min) | 255 | $20,914 | $55 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 25 | $7,048 | $282 |
| Influenza vaccine split virus, preservative free | 42 | $3,018 | $72 |
| Long return visit (40+ min) | 20 | $2,101 | $96 |
| Administration of influenza virus vaccine | 45 | $1,449 | $32 |
| New patient visit (30+ min) | 22 | $1,361 | $62 |
| New patient visit (45+ min) | 18 | $1,332 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,251 | $104 |
| Administration of pneumococcal vaccine | 25 | $805 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 23 | $116 | $5 |
| Urinalysis, manual test | 16 | $58 | $3 |
2022: 8 services
| Return visit (30+ min) | 102 | $9,937 | $73 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 19 | $5,283 | $278 |
| Short return visit (20+ min) | 58 | $3,541 | $56 |
| New patient visit (45+ min) | 27 | $3,385 | $125 |
| Influenza vaccine split virus, preservative free | 27 | $1,851 | $69 |
| Long return visit (40+ min) | 14 | $1,521 | $95 |
| Administration of influenza virus vaccine | 31 | $965 | $31 |
| Administration of pneumococcal vaccine | 18 | $560 | $31 |
Medicaid work
$934 in 2024
Medicaid paid $934 for 30 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 30 | $934 |
| 2024 | 30 | 1 | 16 | $934 |
Drugs they prescribed that Part D paid
$197,130
Pharmacies billed $197,130 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (23 of 2,347) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
2,043 generic and 285 brand-name prescriptions · $197,130 in drug cost · 124 antibiotic prescriptions to 107 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 19 | $19,919 | $1,048 |
| Eliquis | 23 | $19,902 | $865 |
| Jardiance | 18 | $18,256 | $1,014 |
| Incruse Ellipta | 22 | $10,695 | $486 |
| Atorvastatin | 171 | $2,265 | $13 |
See all 51 drugs
| Ozempic | 19 | $19,919 | $1,048 |
| Eliquis | 23 | $19,902 | $865 |
| Jardiance | 18 | $18,256 | $1,014 |
| Incruse Ellipta | 22 | $10,695 | $486 |
| Atorvastatin | 171 | $2,265 | $13 |
| Bupropion Xl | 13 | $2,198 | $169 |
| Albuterol Sulfate Hfa | 52 | $1,934 | $37 |
| Wixela Inhub | 12 | $1,609 | $134 |
| Fluticasone Propionate | 44 | $1,582 | $36 |
| Losartan | 118 | $1,360 | $12 |
| Levothyroxine | 94 | $1,201 | $13 |
| Duloxetine | 26 | $1,130 | $43 |
| Gabapentin | 58 | $1,087 | $19 |
| Amlodipine Besylate | 133 | $991 | $7 |
| Omeprazole | 45 | $971 | $22 |
| Famotidine | 48 | $930 | $19 |
| Baclofen | 17 | $847 | $50 |
| Rosuvastatin | 41 | $831 | $20 |
| Pantoprazole | 65 | $700 | $11 |
| Tamsulosin | 28 | $685 | $24 |
| Montelukast | 33 | $581 | $18 |
| Finasteride | 21 | $466 | $22 |
| Trazodone | 32 | $430 | $13 |
| Lisinopril | 56 | $410 | $7 |
| Losartan-Hydrochlorothiazide | 20 | $352 | $18 |
| Spironolactone | 25 | $340 | $14 |
| Sertraline | 37 | $315 | $9 |
| Azelastine | 13 | $308 | $24 |
| Alendronate | 32 | $302 | $9 |
| Simvastatin | 36 | $289 | $8 |
| Metoprolol | 19 | $284 | $15 |
| Furosemide | 29 | $277 | $10 |
| Allopurinol | 17 | $265 | $16 |
| Escitalopram | 18 | $263 | $15 |
| Benazepril | 12 | $257 | $21 |
| Hydrocodone-Acetaminophen | 14 | $244 | $17 |
| Sumatriptan | 21 | $244 | $12 |
| Valacyclovir | 12 | $243 | $20 |
| Clonidine | 18 | $238 | $13 |
| Hydrochlorothiazide | 40 | $233 | $6 |
| Metformin | 21 | $220 | $10 |
| Amoxicillin-Clavulanate Potass | 31 | $214 | $7 |
| Lovastatin | 13 | $196 | $15 |
| Diclofenac | 12 | $161 | $13 |
| Doxycycline Hyclate | 21 | $149 | $7 |
| Metoprolol | 15 | $136 | $9 |
| Cyclobenzaprine | 11 | $128 | $12 |
| Nitrofurantoin Mono-Macro | 12 | $98 | $8 |
| Prednisone | 31 | $86 | $3 |
| Azithromycin | 15 | $75 | $5 |
| Cephalexin | 19 | $71 | $4 |
Year by year
| 2024 | 2,347 | 430 | 1% (23) | 12% | $197,130 |
| 2023 | 2,719 | 490 | 5% (129) | 11% | $241,276 |
| 2022 | 1,603 | 177 | 1% (16) | None | $156,764 |
| 2021 | 1,661 | 88 | None | None | $180,576 |
| 2020 | 947 | 85 | None | 19% | $78,013 |
| 2019 | 122 | 18 | None | 12% | $6,841 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 70 drugs
| Ozempic | 27 | $32,586 | $1,207 |
| Eliquis | 15 | $16,409 | $1,094 |
| Jardiance | 17 | $15,559 | $915 |
| Spiriva Respimat | 18 | $9,942 | $552 |
| Gabapentin | 89 | $2,536 | $28 |
| Dextroamphetamine-Amphet Er | 14 | $2,374 | $170 |
| Atorvastatin | 148 | $2,029 | $14 |
| Losartan | 105 | $1,951 | $19 |
| Rosuvastatin | 56 | $1,798 | $32 |
| Duloxetine | 39 | $1,760 | $45 |
| Hydrocodone-Acetaminophen | 70 | $1,732 | $25 |
| Butalbital-Acetaminophen-Caffe | 12 | $1,510 | $126 |
| Levothyroxine | 101 | $1,421 | $14 |
| Sertraline | 27 | $1,202 | $45 |
| Bupropion Xl | 17 | $1,150 | $68 |
| Omeprazole | 48 | $1,097 | $23 |
| Amlodipine Besylate | 110 | $935 | $8 |
| Albuterol Sulfate Hfa | 35 | $893 | $26 |
| Famotidine | 40 | $825 | $21 |
| Metoprolol | 34 | $825 | $24 |
| Lisinopril | 64 | $748 | $12 |
| Ventolin Hfa | 12 | $744 | $62 |
| Diclofenac | 19 | $727 | $38 |
| Pregabalin | 17 | $722 | $42 |
| Pantoprazole | 35 | $714 | $20 |
| Potassium Chloride | 17 | $683 | $40 |
| Montelukast | 41 | $662 | $16 |
| Trazodone | 58 | $628 | $11 |
| Nifedipine Er | 11 | $617 | $56 |
| Buprenorphine | 12 | $605 | $50 |
| Estradiol | 11 | $586 | $53 |
| Oxycodone-Acetaminophen | 11 | $558 | $51 |
| Olanzapine | 18 | $526 | $29 |
| Fluticasone Propionate | 30 | $524 | $17 |
| Tamsulosin | 27 | $502 | $19 |
| Spironolactone | 29 | $498 | $17 |
| Metformin | 43 | $497 | $12 |
| Losartan-Hydrochlorothiazide | 19 | $494 | $26 |
| Finasteride | 28 | $493 | $18 |
| Simvastatin | 42 | $488 | $12 |
| Furosemide | 49 | $408 | $8 |
| Nitrofurantoin Mono-Macro | 22 | $392 | $18 |
| Colchicine | 12 | $310 | $26 |
| Nortriptyline | 14 | $305 | $22 |
| Benazepril | 11 | $267 | $24 |
| Alendronate | 26 | $247 | $10 |
| Escitalopram | 15 | $229 | $15 |
| Hydrochlorothiazide | 43 | $227 | $5 |
| Metformin Hcl Er | 11 | $188 | $17 |
| Cyclobenzaprine | 32 | $186 | $6 |
| Sumatriptan | 14 | $169 | $12 |
| Amitriptyline | 16 | $163 | $10 |
| Metoprolol | 18 | $131 | $7 |
| Baclofen | 11 | $129 | $12 |
| Tizanidine | 11 | $123 | $11 |
| Oxycodone | 13 | $115 | $9 |
| Glipizide | 14 | $114 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $110 | $8 |
| Hydrocortisone | 11 | $107 | $10 |
| Clopidogrel | 11 | $96 | $9 |
| Clonidine | 14 | $93 | $7 |
| Lorazepam | 11 | $90 | $8 |
| Zolpidem | 21 | $83 | $4 |
| Tramadol | 25 | $67 | $3 |
| Carvedilol | 11 | $65 | $6 |
| Doxycycline Hyclate | 11 | $58 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $56 | $5 |
| Meloxicam | 19 | $41 | $2 |
| Alprazolam | 11 | $38 | $3 |
| Prednisone | 17 | $32 | $2 |
2022: 42 drugs
| Rybelsus | 34 | $23,968 | $705 |
| Topamax | 14 | $15,078 | $1,077 |
| Keppra | 13 | $15,036 | $1,157 |
| Eliquis | 12 | $11,406 | $950 |
| Jardiance | 12 | $10,195 | $850 |
| Spiriva Respimat | 13 | $6,855 | $527 |
| Anoro Ellipta | 11 | $5,195 | $472 |
| Famotidine | 75 | $3,177 | $42 |
| Rosuvastatin | 42 | $2,367 | $56 |
| Albuterol Sulfate Hfa | 24 | $1,079 | $45 |
| Pregabalin | 18 | $998 | $55 |
| Atorvastatin | 97 | $930 | $10 |
| Sucralfate | 29 | $776 | $27 |
| Gabapentin | 36 | $748 | $21 |
| Olanzapine | 19 | $685 | $36 |
| Lisinopril | 93 | $674 | $7 |
| Levothyroxine | 29 | $644 | $22 |
| Buspirone | 15 | $587 | $39 |
| Omeprazole | 44 | $548 | $12 |
| Nitrofurantoin Mono-Macro | 15 | $515 | $34 |
| Pantoprazole | 23 | $439 | $19 |
| Hydroxyzine | 16 | $414 | $26 |
| Lamotrigine | 20 | $409 | $20 |
| Metformin | 41 | $367 | $9 |
| Sertraline | 33 | $343 | $10 |
| Carvedilol | 12 | $315 | $26 |
| Simvastatin | 30 | $305 | $10 |
| Montelukast | 31 | $304 | $10 |
| Metformin Hcl Er | 34 | $277 | $8 |
| Tamsulosin | 16 | $259 | $16 |
| Paroxetine | 14 | $239 | $17 |
| Pravastatin | 21 | $216 | $10 |
| Amitriptyline | 13 | $201 | $15 |
| Amlodipine Besylate | 32 | $180 | $6 |
| Clonidine | 22 | $171 | $8 |
| Ibuprofen | 14 | $168 | $12 |
| Hydrochlorothiazide | 34 | $146 | $4 |
| Trazodone | 25 | $144 | $6 |
| Metoprolol | 12 | $117 | $10 |
| Losartan | 23 | $110 | $5 |
| Furosemide | 12 | $68 | $6 |
| Prednisone | 11 | $30 | $3 |
2021: 48 drugs
| Topamax | 26 | $26,882 | $1,034 |
| Rybelsus | 17 | $25,533 | $1,502 |
| Jardiance | 23 | $14,501 | $630 |
| Keppra | 14 | $13,932 | $995 |
| Anoro Ellipta | 20 | $9,054 | $453 |
| Famotidine | 93 | $3,710 | $40 |
| Alendronate | 13 | $2,814 | $216 |
| Propafenone Hcl Er | 12 | $1,815 | $151 |
| Rosuvastatin | 16 | $1,337 | $84 |
| Albuterol Sulfate Hfa | 22 | $1,286 | $58 |
| Duloxetine | 15 | $797 | $53 |
| Omeprazole | 71 | $774 | $11 |
| Atorvastatin | 91 | $764 | $8 |
| Olanzapine | 17 | $722 | $42 |
| Buspirone | 16 | $481 | $30 |
| Levothyroxine | 23 | $445 | $19 |
| Metformin | 66 | $409 | $6 |
| Pantoprazole | 30 | $407 | $14 |
| Sucralfate | 17 | $406 | $24 |
| Amitriptyline | 13 | $390 | $30 |
| Estradiol | 17 | $389 | $23 |
| Gabapentin | 22 | $378 | $17 |
| Clonidine | 41 | $359 | $9 |
| Lisinopril | 64 | $359 | $6 |
| Sertraline | 32 | $340 | $11 |
| Metoprolol | 14 | $335 | $24 |
| Potassium Chloride | 13 | $327 | $25 |
| Metformin Hcl Er | 36 | $301 | $8 |
| Venlafaxine Hcl Er | 12 | $301 | $25 |
| Propranolol | 16 | $266 | $17 |
| Paroxetine | 26 | $264 | $10 |
| Trazodone | 20 | $259 | $13 |
| Ibuprofen | 26 | $251 | $10 |
| Pravastatin | 24 | $239 | $10 |
| Lamotrigine | 12 | $238 | $20 |
| Simvastatin | 44 | $237 | $5 |
| Fluticasone Propionate | 14 | $229 | $16 |
| Hydrochlorothiazide | 54 | $205 | $4 |
| Montelukast | 21 | $201 | $10 |
| Nortriptyline | 11 | $188 | $17 |
| Amlodipine Besylate | 38 | $180 | $5 |
| Metoprolol | 16 | $127 | $8 |
| Hydroxyzine | 18 | $123 | $7 |
| Tamsulosin | 12 | $110 | $9 |
| Cyclobenzaprine | 12 | $107 | $9 |
| Furosemide | 18 | $80 | $4 |
| Euthyrox | 17 | $79 | $5 |
| Atenolol | 12 | $42 | $4 |
2020: 25 drugs
| Anoro Ellipta | 11 | $4,839 | $440 |
| Humalog | 17 | $4,586 | $270 |
| Alendronate | 11 | $1,928 | $175 |
| Albuterol Sulfate Hfa | 12 | $666 | $55 |
| Duloxetine | 28 | $618 | $22 |
| Ventolin Hfa | 11 | $612 | $56 |
| Atorvastatin | 41 | $529 | $13 |
| Potassium Chloride | 15 | $425 | $28 |
| Buspirone | 18 | $370 | $21 |
| Amitriptyline | 13 | $321 | $25 |
| Omeprazole | 23 | $261 | $11 |
| Metformin | 46 | $258 | $6 |
| Famotidine | 25 | $240 | $10 |
| Amlodipine Besylate | 25 | $225 | $9 |
| Pantoprazole | 13 | $212 | $16 |
| Levothyroxine | 11 | $180 | $16 |
| Ibuprofen | 19 | $163 | $9 |
| Hydrochlorothiazide | 28 | $153 | $5 |
| Lisinopril | 29 | $144 | $5 |
| Propranolol | 12 | $134 | $11 |
| Simvastatin | 29 | $131 | $5 |
| Sertraline | 19 | $116 | $6 |
| Euthyrox | 14 | $56 | $4 |
| Furosemide | 17 | $55 | $3 |
| Citalopram Hbr | 12 | $30 | $2 |
Professional record
- NPI
- 1649730680
- Licence
- CA 20A19422
- Trained
- Rocky Vista University College of Osteopathic Med, 2019
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 255228, Sacramento, CA, 95865
- NPI first listed
- 2019-03-25
- NPI last updated
- 2024-09-09
- NPI record certified
- 2024-09-09
This is when the NPI record was last certified, not a medical board exam.